Page:United States Statutes at Large Volume 106 Part 3.djvu/565

 PUBLIC LAW 102-484—OCT. 23, 1992 106 STAT. 2359 measures against biowarfare threat agents only in accordance with this section. (2) Of the funds made available pursuant to subsection (a), not more than $10,000,000 may be obligated or expended for research, development, test, or evaluation of medical countermeasures against far-term validated biowarfare threat agents. (3) Of Uie funds made available pursuant to subsection (a) other than funds made available pursuant to paragraph (2) for the purpose set out in that paragraph— (A) not more than 80 percent may be obligated and expended for product development, or for research, development, test, or evaluation, of medical countermeasures against near-term validated biowarfare threat agents; and (B) not more than 20 percent may be obligated or expended for product development, or for research, development, test, or evaluation, of medical countermeasures against mid-term validated biowarfare threat agents. (c) DEFINITIONS.— In this section: (1) The term 'Validated biowarfare threat agent" means a biological agent that— (A) is named in the biological warfare threat list published by the Defense Intelligence Agency; and (B) is identified as a biowarfare threat by the Deputy Chief of Staff of the Army for Intelligence in accordance with Army regulations applicable to mtelligence support for the medical component of the Biological Defense Research Program. (2) The term near-term validated biowarfare threat agent" means a validated biowarfare threat agent that has been, or is being, developed or produced for weaponization within 5 years, as assessed and aetermined by the Defense Intelligence Agency. (3) The term "mid-term validated biowarfare threat agent" means a validated biowarfare threat agent that is an emerging biowarfare threat, is the object of research by a foreign threat coiuitry, and will be ready for weaponization in more than 5 years and less than 10 years, as assessed and determined by the Defense Intelligence Agency. (4) The term "far-term validated biowarfare threat agent" means a validated biowarfare threat agent that is a future biowarfare threat, is the object of research by a foreign threat country, and could be ready for weaponization in more than 10 years and less than 20 years, as assessed and determined by the Defense Intelligence Agency. (5) The term "weaponization" metms incorporation into usable ordnance or other militarily useful means of delivery. SEC. 242. NATIONAL AERO-SPACE PLANE. (a) FUNDING LIMITATION. —Notwithstanding any other provision of law, funds made available to the Department of Defense may not be obligated for the National Aero-Space Plane program for any fiscal year in an amount greater than twice the amount provided for that program in the appropriations Act making appropriations for that nsc^ year for the Department of Housing and Urban Development and for independent agencies. (b) EFFECTIVE DATE. — Subsection (a) applies with respect to fiscal years after fiscal year 1993.

�